XBiotech Ownership | Who Owns XBiotech?
XBiotech Ownership Summary
XBiotech is owned by 14.84% institutional investors, 35.13% insiders, and 50.03% retail investors. Blackrock is the largest institutional shareholder, holding 3.73% of XBIT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.05% of its assets in XBiotech shares.
XBIT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | XBiotech | 14.84% | 35.13% | 50.03% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 623.36K | 2.05% | - |
iShares Russell 2000 ETF | 450.93K | 1.48% | -1.01K |
Vanguard Institutional Extnd Mkt Idx Tr | 292.55K | 0.96% | - |
iShares Russell 2000 Value ETF | 187.80K | 0.62% | - |
Fidelity Small Cap Index | 186.99K | 0.61% | -2.09K |
Fidelity Extended Market Index | 114.59K | 0.38% | -1.33K |
Avantis US Small Cap Value ETF | 106.59K | 0.35% | - |
Vanguard Russell 2000 ETF | 90.96K | 0.30% | -578.00 |
State St Russell Sm Cap® Indx SL Cl I | 90.50K | 0.30% | - |
Bridgeway Ultra-Small Company | 65.04K | 0.21% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 03, 2024 | SIMARD JOHN | Chief Executive Officer | Buy | $10.00M |
Oct 18, 2021 | SIMARD JOHN | Chief Executive Officer | Sell | $431.25K |
Oct 15, 2021 | SIMARD JOHN | Chief Executive Officer | Sell | $226.47K |
Oct 13, 2021 | SIMARD JOHN | Chief Executive Officer | Sell | $139.53K |
Oct 12, 2021 | SIMARD JOHN | Chief Executive Officer | Sell | $229.94K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | - | - |
2024 Q1 | 1 | - |
2023 Q3 | - | - |
2023 Q2 | - | - |
2023 Q1 | - | - |
XBIT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools